Long-term results of a phase 2 study of neoadjuvant chemotherapy with molecularly targeted agents for locally advanced rectal cancer.
Aoyama R, Hida K, Hasegawa S, Yamaguchi T, Manaka D, Kato S, Yamada M, Yamanokuchi S, Kyogoku T, Kanazawa A, Kawada K, Sakamoto T, Goto S, Sakai Y, Obama K.
Aoyama R, et al. Among authors: sakamoto t.
Int J Clin Oncol. 2023 Mar;28(3):392-399. doi: 10.1007/s10147-023-02291-4. Epub 2023 Jan 9.
Int J Clin Oncol. 2023.
PMID: 36622469
Clinical Trial.